An algorithm framework based on CycleGAN and an upgraded dual-path network (DPN) is suggested to address the difficulties of uneven staining in pathological pictures and difficulty of discriminating benign from malignant cells. CycleGAN is used for color normalization in pathological pictures to tackle the problem of uneven staining. However, the resultant detection model is ineffective. By overlapping the images, the DPN uses the addition of small convolution, deconvolution, and attention mechanisms to enhance the model's ability to classify the texture features of pathological images on the BreaKHis dataset. The parameters that are taken into consideration for measuring the accuracy of the proposed model are false-positive rate, false-negative rate, recall, precision, and F1 score. Several experiments are carried out over the selected parameters, such as making comparisons between benign and malignant classification accuracy under different normalization methods, comparison of accuracy of image level and patient level using different CNN models, correlating the correctness of DPN68-A network with different deep learning models and other classification algorithms at all magnifications. The results thus obtained have proved that the proposed model DPN68-A network can effectively classify the benign and malignant breast cancer pathological images at various magnifications. The proposed model also is able to better assist the pathologists in diagnosing the patients by synthesizing the images of different magnifications in the clinical stage.
Cyclic GAN Model to Classify Breast Cancer Data for Pathological Healthcare Task.
阅读:4
作者:Chopra Pooja, Junath N, Singh Sitesh Kumar, Khan Shakir, Sugumar R, Bhowmick Mithun
| 期刊: | Biomed Research International | 影响因子: | 2.300 |
| 时间: | 2022 | 起止号: | 2022 Jul 21; 2022:6336700 |
| doi: | 10.1155/2022/6336700 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
